Telemonitoring with SpA-Net
- Conditions
- <p>Spondyloarthritis</p>Axial and/or peripheral spondyloarthritis, psoriatic arthritis, ankylosing spondylitis10003816
- Registration Number
- NL-OMON25783
- Lead Sponsor
- ReumaNederland
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
In order to be eligible for participation in this study, subjects must meet all of the following criteria: • Adult patient (18+ years) • Diagnosis of SpA according to treating physician • At least 2 years of disease duration, to be familiar with signs, symptoms, and medication • Stable disease, defined as being in a patient acceptable symptom state according to patient AND treating physician (36) AND no treatment change expected in the next few months • Access to a computer, tablet and/or smartphone for the entire duration of the study
A potential subject who meets any of the following criteria will be excluded from participation in this study: • Insufficient mastery of Dutch language • Incompetent to act for oneself • Limited life expectancy • Ongoing (or planned) pregnancy during the study period • Patients participating in other research project(s)
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>At least 25% reduction in the number of scheduled and unscheduled outpatient visits to the rheumatology department in the telemonitoring group compared to the standard care group within a 1-year follow-up period.</p><br>
- Secondary Outcome Measures
Name Time Method <p>• Non-inferiority of telemonitoring compared to standard care with respect to quality of care and health outcomes. • Non-inferiority with respect to experience with SpA-Net and general rheumatological care. • Association between patient-reported self-management skills and successful application of telemonitoring • Experience with telemonitoring through SpA-Net among care providers • Difference between the populations with regard to healthcare cost per quality adjusted life year (QALY) gained after 1 year • Difference between the populations with regard to societal cost per QALY gained after 1 year</p><br>